Form 4 for PALI PALISADE BIO, INC.
Accepted 2026-07-08 18:52:59 ET · period of report 2026-07-06 · accession 0001493152-26-032561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-08 18:52 | 2026-07-06 | PALI | Jones Mitchell Lawrence | Chief Medical Off | M - OptEx | — | +131.2K | 145.9K | +891% | — |
| D | 2026-07-08 18:52 | 2026-07-07 | PALI | Jones Mitchell Lawrence | Chief Medical Off | S - Sale+OE | $2.05 | -51.9K | 94.0K | -36% | -$106.5K |
| D | 2026-07-08 18:52 | 2026-07-06 | PALI | Jones Mitchell Lawrence | Chief Medical Off | M - OptEx | $0.00 | -131.2K | 655.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-06 | M | A | 131,167 | — | 145,889 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026. (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026. (F2) Includes 1,459 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. |
| 2 | Common | Common Stock | 2026-07-07 | S | D | 51,880 | $2.05 | 94,009 | D | — | — | (F3) The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Restricted Stock Units | 2026-07-06 | M | D | 131,167 | $0.00 | 655,833 | D | — · — to — | 131,167 Common Stock | (F5) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F6) The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. (F6) The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |